Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Medline Inc.. A complete text table follows the diagram.
Supply Chain Solutions is now the larger and faster-growing revenue engine, but Medline's own clinical products generate four-fifths of segment Adjusted EBITDA.
Swipe to explore
All Sankey flows are reported GAAP amounts. Company-defined segment Adjusted EBITDA and margins appear only in annotations and secondary labels. The narrative compares the growth and margin roles of the two reported segments without allocating consolidated costs between them.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Front Line Care | 1 | $1.6B | Everyday clinical products |
| Surgical Solutions | 1 | $1.6B | Procedure and operating-room products |
| Laboratory & Diagnostics | 1 | $293M | Branded diagnostic supplies |
| Supply Chain Solutions | 1 | $3.9B | Source, distribute and manage inventory |
| Healthcare supply-platform sales | 2 | $7.4B | 10.7% year-over-year growth |
| Source & manufacture medical supplies | 3 | $5.5B | Reported cost of goods sold |
| Gross profit | 3 | $1.8B | 25.0% margin; up only 0.9% |
| Sell, deliver & operate the network | 4 | $1.2B | Reported SG&A |
| Intangible-asset amortization | 4 | $176M | Reported expense |
| Other operating expense | 4 | $15M | Reported expense |
| Operating income | 4 | $422M | Down 26.1% year over year |
| Interest, FX & other expense | 5 | $131M | Reported net non-operating cost |
| Income before tax | 5 | $291M | Reported pretax result |
| Income tax | 6 | $52M | Reported provision |
| Consolidated net income | 6 | $239M | Reported consolidated result |
| Noncontrolling interests | 7 | $110M | Reported attribution |
| Net income attributable to Medline | 7 | $129M | $0.16 per diluted share |
| From | To | Value |
|---|---|---|
| Front Line Care | Healthcare supply-platform sales | $1.6B |
| Surgical Solutions | Healthcare supply-platform sales | $1.6B |
| Laboratory & Diagnostics | Healthcare supply-platform sales | $293M |
| Supply Chain Solutions | Healthcare supply-platform sales | $3.9B |
| Healthcare supply-platform sales | Source & manufacture medical supplies | $5.5B |
| Healthcare supply-platform sales | Gross profit | $1.8B |
| Gross profit | Sell, deliver & operate the network | $1.2B |
| Gross profit | Intangible-asset amortization | $176M |
| Gross profit | Other operating expense | $15M |
| Gross profit | Operating income | $422M |
| Operating income | Interest, FX & other expense | $131M |
| Operating income | Income before tax | $291M |
| Income before tax | Income tax | $52M |
| Income before tax | Consolidated net income | $239M |
| Consolidated net income | Noncontrolling interests | $110M |
| Consolidated net income | Net income attributable to Medline | $129M |